Effectiveness of treatment with pegylated interferon and ribavirin in an unselected population of patients with chronic hepatitis C: a Danish nationwide cohort study

Nanna Hansen, Niels Obel, Peer Christensen, Mette Skalshøi Kjær, Alex Lund Laursen, Henrik Bygum Krarup, Axel Møller, Poul Schlichting, Jens Bukh, Nina Margrethe Weis, Danish Database for Hepatitis B and C (DANHEP)- group, Peter Nørregaard, Suzanne Lunding

23 Citationer (Scopus)

Abstract

The effect of peginterferon and ribavirin treatment on chronic hepatitis C virus (HCV) infection has been established in several controlled clinical studies. However, the effectiveness of treatment and predictors of treatment success in routine clinical practice remains to be established. Our aim was to estimate the effectiveness of peginterferon and ribavirin treatment in unselected HCV patients handled in routine clinical practice. The endpoint was sustained virological response (SVR), determined by the absence of HCV RNA 24 weeks after the end of treatment.
OriginalsprogEngelsk
TidsskriftB M C Infectious Diseases
Vol/bind11
Sider (fra-til)177
ISSN1471-2334
DOI
StatusUdgivet - 1 jan. 2011

Fingeraftryk

Dyk ned i forskningsemnerne om 'Effectiveness of treatment with pegylated interferon and ribavirin in an unselected population of patients with chronic hepatitis C: a Danish nationwide cohort study'. Sammen danner de et unikt fingeraftryk.

Citationsformater